在接受连续脏替代疗法的危急病患者中,尼马特里尔维尔/里托纳维尔的高度
Rong Dong1, Yizhen Huang2, Xiao Ling3
1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China; Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
作为一种有效的COVID-19治疗方法的尼尔马特雷尔维尔/里托纳维尔,在接受连续脏替代疗法 (CRRT) 的患者中显示出更高的度. 建议对这些重症患者进行剂量减少,以确保安全性和有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 尼尔马特里尔维尔/里托纳维尔是SARS-CoV-2的主要抗病毒药物.
- 标准剂量指南缺乏持续置换疗法 (CRRT) 患者的建议.
研究的目的:
- 在接受CRRT的中国重症患者中,鉴定尼马特里尔维尔/里托纳维尔水平.
- 为了为这种脆弱的患者群体进行剂量调整提供信息.
主要方法:
- 尼尔马特里尔维尔/里托纳维尔进行了治疗药物监测.
- 使用了高性能液体色谱学并联质谱测试方法.
- 包括8名接受CRRT的危急病患者.
主要成果:
- 涅马特里尔维尔的最低度显著升高,从3325.34到15625.46 ng/mL不等.
- 度高达正常功能患者的7倍.
- 与血液透析的末期脏病患者相比,水平大约高出2倍.
结论:
- 在CRRT患者中尼马特里尔维尔/里托纳维尔度升高表明需要调整剂量.
- 推对CRRT患者实施剂量降低.
相关概念视频
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...


